The Neuroenteric Clinical Research Group, Southern Arizona VA Health Care System, Tucson, USA.
Aliment Pharmacol Ther. 2011 Dec;34(11-12):1295-305. doi: 10.1111/j.1365-2036.2011.04870.x. Epub 2011 Oct 17.
BACKGROUND A potential relationship has been suggested between gastro-oesophageal reflux disease (GERD) and interstitial lung diseases (ILDs). AIM To evaluate whether there is a causal relationship between GERD and different ILDs. METHODS We conducted a systematic search of literature published between 1980 and 2010. After a review by two independent authors, each study was assigned an evidence-based rating according to a standard scoring system. RESULTS We identified 319 publications and 22 of them met the entry criteria. Of those, the relationship between GERD and idiopathic pulmonary fibrosis (IPF) was investigated in 14 articles, pulmonary involvement in systemic sclerosis (SSc) in six articles and pulmonary involvement in mixed connective tissue disease (MCTD) in two articles. We found the prevalence of GERD and/or oesophageal dysmotility to be higher in patients with different types of ILD as compared with those without ILD [Evidence B]. Among patients with IPF, 67-76% demonstrated abnormal oesophageal acid exposure off PPI treatment. No relationship was demonstrated between severity of GERD and severity of IPF [Evidence B]. Data are scant on outcomes of antireflux treatment in patients with IPF. There is a correlation between the severity of ILD and the degree of oesophageal motor impairment in patients with SSc and MCTD [Evidence B]. CONCLUSIONS Based on the currently available data, a causal relationship between GERD and idiopathic pulmonary fibrosis cannot be established. There is scant evidence about antireflux therapy in idiopathic pulmonary fibrosis patients. There may be an association between lung and oesophageal involvement in systemic sclerosis and mixed connective tissue disease, but a causal relationship cannot be established.
胃食管反流病(GERD)和间质性肺疾病(ILDs)之间可能存在关联。
评估 GERD 和不同 ILD 之间是否存在因果关系。
我们对 1980 年至 2010 年间发表的文献进行了系统搜索。经过两位独立作者的审查,根据标准评分系统对每项研究进行了证据分级。
我们确定了 319 篇出版物,其中 22 篇符合入选标准。在这些研究中,有 14 篇研究了 GERD 与特发性肺纤维化(IPF)的关系,6 篇研究了系统性硬化症(SSc)中的肺受累,2 篇研究了混合性结缔组织病(MCTD)中的肺受累。我们发现,与无 ILD 者相比,不同类型 ILD 患者 GERD 和/或食管动力障碍的患病率更高[证据 B]。在 IPF 患者中,67-76%的患者在停用 PPI 后出现异常的食管酸暴露。GERD 的严重程度与 IPF 的严重程度之间未显示出相关性[证据 B]。关于 IPF 患者抗反流治疗的结果数据很少。在 SSc 和 MCTD 患者中,ILD 的严重程度与食管运动障碍的程度之间存在相关性[证据 B]。
根据目前可用的数据,无法确定 GERD 和特发性肺纤维化之间存在因果关系。关于 IPF 患者抗反流治疗的证据很少。SSc 和 MCTD 中可能存在肺和食管受累之间的关联,但不能建立因果关系。